Tourmaline Bio, Inc.

NASDAQ (USD): Tourmaline Bio, Inc. (TRML)

Last Price

14.99

Today's Change

-0.99 (6.19%)

Day's Change

14.90 - 16.10

Trading Volume

523,474

Overview

Market Cap

384 Million

Shares Outstanding

25 Million

Avg Volume

226,878

Avg Price (50 Days)

20.73

Avg Price (200 Days)

19.11

PE Ratio

-6.02

EPS

-2.49

Earnings Announcement

17-Mar-2025

Previous Close

15.98

Open

15.99

Day's Range

14.9 - 16.1

Year Range

12.12 - 48.31

Trading Volume

539,503

Price Change Highlight

1 Day Change

-6.20%

5 Day Change

-8.88%

1 Month Change

-31.05%

3 Month Change

-45.29%

6 Month Change

2.53%

Ytd Change

-27.37%

1 Year Change

-59.32%

3 Year Change

-84.39%

5 Year Change

-90.78%

10 Year Change

-90.78%

Max Change

-90.78%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment